Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1976-1-26
|
pubmed:abstractText |
A total of 1,355 patients from clinical trails with the 99mTc-labeled bone agent, Osteoscan (99mTc-Sn -EHDP), has shown a higher incidence of skeletal abnormalities than previously reported. Overall in this study, 60% of bone scans were abnormal in patients with nonosseous neoplasms. Carcinoma of breast, lung, and prostate yielded 67%, 64%, and 62% skeletal involvement, respectively. Over 50% of all the skeletal abnormalities for the neoplastic indications were detected in the thorax and vertebra while the skull, pelvis, and extremities accounted for 22%, 38%, and 34%, respectively.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0161-5505
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
986-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:810549-Bone Neoplasms,
pubmed-meshheading:810549-Breast Neoplasms,
pubmed-meshheading:810549-Etidronic Acid,
pubmed-meshheading:810549-Female,
pubmed-meshheading:810549-Humans,
pubmed-meshheading:810549-Lung Neoplasms,
pubmed-meshheading:810549-Male,
pubmed-meshheading:810549-Neoplasm Metastasis,
pubmed-meshheading:810549-Organophosphorus Compounds,
pubmed-meshheading:810549-Prostatic Neoplasms,
pubmed-meshheading:810549-Radionuclide Imaging,
pubmed-meshheading:810549-Technetium
|
pubmed:year |
1975
|
pubmed:articleTitle |
Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.
|
pubmed:publicationType |
Journal Article
|